686 related articles for article (PubMed ID: 25091063)
1. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
Amiot A; Setakhr V; Seksik P; Allez M; Treton X; De Vos M; Laharie D; Colombel JF; Abitbol V; Reimund JM; Moreau J; Veyrac M; Flourié B; Cosnes J; Lemann M; Bouhnik Y
Am J Gastroenterol; 2014 Sep; 109(9):1443-9. PubMed ID: 25091063
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
[TBL] [Abstract][Full Text] [Related]
3. Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
Le Baut G; Peyrin-Biroulet L; Bouguen G; Gornet JM; Stefanescu C; Amiot A; Laharie D; Altwegg R; Fumery M; Trang C; Vuitton L; Simon M; Gilletta de Saint Joseph C; Nahon S; Caillo L; Del Tedesco E; Plastaras L; Aubourg A; Pineton de Chambrun G; Seksik P; Viennot S
Aliment Pharmacol Ther; 2018 Oct; 48(8):831-838. PubMed ID: 30194687
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy.
Castaño-Milla C; Chaparro M; Saro C; Barreiro-de Acosta M; García-Albert AM; Bujanda L; Martín-Arranz MD; Carpio D; Muñoz F; Manceñido N; García-Planella E; Piqueras M; Calvet X; Cabriada JL; Botella B; Bermejo F; Gisbert JP
J Clin Gastroenterol; 2015 Jan; 49(1):34-40. PubMed ID: 25485513
[TBL] [Abstract][Full Text] [Related]
7. [Recurrent Crohn's disease in the ileocolonic anastomosis complicated with duodenal fistula].
Ghidirim G; Ignatenco S; Mişin I; Gagauz I; Tiple I; Cuţitari I; Zastavniţchi G
Chirurgia (Bucur); 2007; 102(5):607-10. PubMed ID: 18018365
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
9. Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn's disease.
Fries W; La Malfa G; Costantino G; Repici A; Mazziotti S; Navarra G
Inflamm Bowel Dis; 2011 Feb; 17(2):671-3. PubMed ID: 20848472
[No Abstract] [Full Text] [Related]
10. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S
Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for the treatment of fistulas in patients with Crohn's disease.
Present DH; Rutgeerts P; Targan S; Hanauer SB; Mayer L; van Hogezand RA; Podolsky DK; Sands BE; Braakman T; DeWoody KL; Schaible TF; van Deventer SJ
N Engl J Med; 1999 May; 340(18):1398-405. PubMed ID: 10228190
[TBL] [Abstract][Full Text] [Related]
12. Complete resolution of enterocolic fistulas with infliximab.
Nunes J; Santos PM; Tavares L
BioDrugs; 2010 Dec; 24 Suppl 1():28-30. PubMed ID: 21175233
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Surgery for Coloduodenal Fistula in Crohn's Disease.
Gong J; Wei Y; Gu L; Li Y; Guo Z; Sun J; Ding C; Zhu W; Li N; Li J
J Gastrointest Surg; 2016 May; 20(5):976-84. PubMed ID: 26718702
[TBL] [Abstract][Full Text] [Related]
14. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
15. Definitive surgical closure of enterocutaneous fistula: outcome and factors predictive of increased postoperative morbidity.
Ravindran P; Ansari N; Young CJ; Solomon MJ
Colorectal Dis; 2014 Mar; 16(3):209-18. PubMed ID: 24521276
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.
Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA
Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease.
Bouguen G; Huguet A; Amiot A; Viennot S; Cholet F; Nachury M; Flamant M; Reimund JM; Desfourneaux V; Boureille A; Siproudhis L;
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):628-636. PubMed ID: 31128337
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
Fortea-Ormaechea JI; González-Lama Y; Casis B; Chaparro M; López Serrano P; Van Domselaar M; Bermejo F; Pajares R; Ponferrada A; Vera MI; Martínez Montiel P; Gisbert JP; Pérez-Calle JL; López San Román A; Abreu L; Menchén LA; Marín-Jiménez I
Gastroenterol Hepatol; 2011; 34(7):443-8. PubMed ID: 21724297
[TBL] [Abstract][Full Text] [Related]
20. Infliximab in fistulizing Crohn's disease.
Osterman MT; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]